Description

Moxifloxacin CAS NO 158060-78-7 is a synthetic broad-spectrum fluoroquinolone antibiotic belonging to the fourth generation of its class. It is valued for its enhanced activity against Gram-positive bacteria, atypical pathogens, and anaerobes, while maintaining potency against Gram-negative organisms. This makes it a critical active pharmaceutical ingredient (API) primarily for the pharmaceutical industry, where it is formulated into ophthalmic solutions for bacterial conjunctivitis and systemic medications for respiratory tract and skin infections.

Application

• Ophthalmic Solutions: Primary use as the active ingredient in eye drops and ointments for treating bacterial conjunctivitis and other ocular infections.
• Systemic Antibiotic Formulations: Used in the manufacture of oral tablets and intravenous solutions for combating community-acquired pneumonia, acute bacterial sinusitis, and skin structure infections.
• Pharmaceutical Intermediates: Serves as a key building block in the synthesis of more complex fluoroquinolone derivatives and novel drug candidates under research.
• Veterinary Medicine: Applied in certain veterinary pharmaceutical preparations for treating bacterial infections in animals, subject to regional regulatory approvals.
• Reference Standards: Supplied in high-purity grades for use as analytical reference standards in quality control laboratories for drug testing and method validation.
• Research & Development: Utilized in microbiological and pharmacological research to study antibiotic resistance mechanisms and develop new combination therapies.

Basic Information

Product Name	Moxifloxacin
CAS No.	158060-78-7
Molecular Formula	C21H24FN3O4
Molecular Weight	401.43 g/mol
Synonyms	Moxifloxacin Hydrochloride (common salt form); BAY 12-8039; Avelox (Brand Name); 1-Cyclopropyl-7-[(S,S)-2,8-diazabicyclo[4.3.0]non-8-yl]-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Moxifloxacinum; Moxifloxacine; Moxifloxacino
EINECS	Contact for details

Quality Control

Our Moxifloxacin is manufactured under strict quality management systems. It is typically tested to meet high-purity pharmacopeial standards, with specifications aligning with USP/EP monographs where applicable. Every batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles, ensuring traceability and compliance for GMP-driven applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent absorption of moisture. For long-term storage, consider desiccants.

Specification

Item	Specification
Appearance	Yellow to light yellow crystalline powder
Identification (IR)	Conforms to standard
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.5%
Water Content (KF)	≤ 2.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 2.0%
Microbial Limits	Meets standard requirements

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.